[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 7068 Introduced in House (IH)]

<DOC>






118th CONGRESS
  2d Session
                                H. R. 7068

To amend the Controlled Substances Act to provide for the scheduling of 
    tianeptine as a schedule III substance, and for other purposes.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                            January 22, 2024

  Mr. Panetta (for himself and Mr. Pfluger) introduced the following 
 bill; which was referred to the Committee on Energy and Commerce, and 
   in addition to the Committee on the Judiciary, for a period to be 
subsequently determined by the Speaker, in each case for consideration 
  of such provisions as fall within the jurisdiction of the committee 
                               concerned

_______________________________________________________________________

                                 A BILL


 
To amend the Controlled Substances Act to provide for the scheduling of 
    tianeptine as a schedule III substance, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Scheduling Tianeptine and Analogues 
Now to Defend Against Emerging Opioids Act'' or the ``STAND Against 
Emerging Opioids Act''.

SEC. 2. SCHEDULING OF TIANEPTINE.

    (a) In General.--Section 202(c) of the Controlled Substances Act 
(21 U.S.C. 812(c)) is amended by adding at the end of schedule III the 
following:
    ``(f) Tianeptine, including its analogues, salts, isomers, and 
salts of isomers.''.
    (b) Effective Date.--The amendment made by subsection (a) shall 
become effective on the date that is 90 days after the date of 
enactment of this Act.
                                 <all>